Literature DB >> 28543778

Oral flora in acute stroke patients: A prospective exploratory observational study.

Elizabeth Boaden1, Mary Lyons1, Sim K Singhrao2, Hazel Dickinson1, Michael Leathley1, Catherine E Lightbody1, Alison McLoughlin1, Zarine Khan2, Stjohn Crean2, Craig Smith3, Susan Higham4, Caroline Watkins1,5.   

Abstract

OBJECTIVE: To describe the bacterial profile of the oral flora during the first 2 weeks following a stroke, examining changes in the condition of the oral cavity and infections.
BACKGROUND: Dysphagia is common after a stroke and can lead to aspiration pneumonia. Oral flora changes associated with stroke have been implicated as a possible source of bacteria that can cause systemic infections.
MATERIALS AND METHODS: Seventy-seven participants were recruited over a period of 9 months. Fifty participants had a complete set of swabs from four different oral sites and a saliva sample taken at three time points over a 14-day period. Molecular identification of bacteria was performed on the pooled DNA extracted.
RESULTS: A total of 103 bacterial phylotypes were identified, 29 of which were not in the Human Oral Microbiome Database (HOMD). Fourteen of the twenty most common bacterial phylotypes found in the oral cavity were Streptococcal species with Streptococcus salivarius being the most common. The condition of the oral cavity worsened during the study period. Fifteen (30%) patients had at least one infection.
CONCLUSIONS: There appears to be huge diversity of bacterial organisms in the oral cavity of stroke patients, and as most phylotypes identified were only found in one or two participants, no particular patterns linked to infection or the condition of the oral cavity could be discerned.
© 2017 The Authors. Gerodontology published by The Gerodontology Association and John Wiley & Sons Ltd.

Entities:  

Keywords:  infection; oral care; oral hygiene; stroke

Mesh:

Substances:

Year:  2017        PMID: 28543778     DOI: 10.1111/ger.12271

Source DB:  PubMed          Journal:  Gerodontology        ISSN: 0734-0664            Impact factor:   2.980


  6 in total

1.  Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity.

Authors:  Anne I Boullerne; Guy R Adami; Joel L Schwartz; Demetrios Skias; Mark Maienschein-Cline; Stefan J Green; Douglas L Feinstein
Journal:  J Neuroimmunol       Date:  2020-04-07       Impact factor: 3.478

Review 2.  Oral care after stroke: Where are we now?

Authors:  Mary Lyons; Craig Smith; Elizabeth Boaden; Marian C Brady; Paul Brocklehurst; Hazel Dickinson; Shaheen Hamdy; Susan Higham; Peter Langhorne; Catherine Lightbody; Giles McCracken; Antonieta Medina-Lara; Lise Sproson; Angus Walls; Dame Caroline Watkins
Journal:  Eur Stroke J       Date:  2018-05-08

3.  Exploring the microbiota of upper respiratory tract during the development of pneumonia in a mouse model.

Authors:  Yoshitomo Morinaga; Yuki Take; Daisuke Sasaki; Kenji Ota; Norihito Kaku; Naoki Uno; Kei Sakamoto; Kosuke Kosai; Taiga Miyazaki; Hiroo Hasegawa; Koichi Izumikawa; Hiroshi Mukae; Katsunori Yanagihara
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

4.  Microbiome and ischemic stroke: A systematic review.

Authors:  Yee Teng Lee; Nor Ismaliza Mohd Ismail; Loo Keat Wei
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

5.  Microbiology and Outcomes of Institutionalized Patients With Stroke-Associated Pneumonia: An Observational Cohort Study.

Authors:  Jie Zhao; Lei-Qing Li; Ning-Xin Zhen; Lin-Lin Du; Hui Shan; Yang Yu; Zhao-Cai Zhang; Wei Cui; Bao-Ping Tian
Journal:  Front Microbiol       Date:  2021-12-03       Impact factor: 5.640

6.  The Influence of Periodontal Diseases and the Stimulation of Saliva Secretion on the Course of the Acute Phase of Ischemic Stroke.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Agnieszka Meller; Anna Dziewulska; Alicja Zawiślak; Katarzyna Grocholewicz; Przemysław Nowacki; Marta Masztalewicz
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.